Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.
about
The metabolic and mitogenic properties of basal insulin analoguesInsulin-like growth factor-1 deficiency and metabolic syndromeMecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEXPOTENTIAL NON-GROWTH USES OF rhIGF-IEffect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS).Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians.Advancing age and insulin resistance: new facts about an ancient history.Lipoprotein(a) and risk of type 2 diabetesThe role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.Reversal of type 1 diabetes in mice by brown adipose tissue transplant.Successful rhIGF1 treatment for over 5 years in a patient with severe insulin resistance due to homozygous insulin receptor mutation.Role of IGF-1 in glucose regulation and cardiovascular disease.Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects.Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.The role of liver-derived insulin-like growth factor-I.Diabetes, insulin, and development of acute lung injury.Integrating insulin-like growth factor 1 and sex hormones into neuroprotection: Implications for diabetes.Adipose tissue, hormones, and treatment of type 1 diabetes.Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.Gestational diabetes mellitus and glucose intolerance among Mexican pregnant adolescents.Low plasma insulin-like growth factor-1 concentrations predict worsening of insulin-mediated glucose uptake in older people.Identification of a nonpeptide ligand that releases bioactive insulin-like growth factor-I from its binding protein complex.Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture.Decreased dopaminergic tone and increased basal bioactive prolactin in men with human immunodeficiency virus infection.Serum prolactin is associated with apoptosis in men with human immunodeficiency virus infection.Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence.Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.Low serum insulin-like growth factor-binding protein-1 is associated with an unfavourable cardiovascular risk profile in elderly men.Insulin-like growth factor-I lowers fasting and postprandial triglyceride levels without affecting chylomicron clearance in healthy men.rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
P2860
Q26991486-29BCC16C-B3B6-4E89-92FF-DE40E3EFC25DQ28072410-8F1FFE6D-3145-4908-A4CB-FFC3F3A5AC19Q28273812-DC2B9C45-3763-4CDE-92D5-86DEFB7C1277Q30492205-8A30D05B-3169-4B70-84B4-DACE5FDFDAE0Q32066576-109C27A8-28BA-4390-8656-2B9C69811E9CQ32164773-089D2C6D-471E-4A0C-BCBB-FC68744141E7Q33723742-8163C0D8-CD75-4BE7-BDA9-A4A511F20A3FQ34029711-02536639-2CD0-47A8-8F90-2ABD427D4EA9Q34127704-86C1513A-3B18-40D6-B09E-5532B368A009Q35766895-07809720-B468-49FD-AAE6-F443C0557F85Q36573050-00AF516A-3499-4AAF-8EAF-5A03FD82CB7AQ37269401-2C24C7D1-7AAE-4870-AC12-F917193B6F9BQ37350108-E30D04DE-C0AF-4040-80D0-496BD82235ACQ37362223-6BE554D5-627D-451E-8631-6F2A32770A35Q37367772-7E85DA75-359F-4A03-AA6D-E668F593C0FBQ37381848-D481AF5C-501F-4DD2-9DF7-EB2739336FB8Q37521491-0C033912-1130-47E3-A4DB-D9C0F1FA5543Q37658425-016B9EC7-6A58-4411-A462-D1D85783406DQ38027744-FAD850A9-D5A6-40D9-BCE3-CC8E3E441132Q38239532-2383B407-ADC5-4C61-AC9B-9E005C334718Q38729143-52961DCE-745B-4ADC-91C5-ABDC78898F90Q40592863-B2E1215B-B72A-49C2-8567-FB13B71ADB5FQ40788823-B3C74167-007C-479E-9B33-A7C9913D2FE2Q40793635-22863D47-9E54-4F5A-BCC0-D6A66FC55A6BQ42162185-835AD5B3-3906-40C9-90AD-82A83D617B3BQ42506271-70B9CC50-B884-4E02-8C51-EC5FC64D835DQ43623013-449FB2BD-62CB-4E5C-917C-793512AFB220Q43709429-D2569892-82C0-42F9-A3FC-2F76E35C9B62Q51367271-C2739D9B-7E13-4ED3-A76D-6D75ABD39CFBQ51543747-D8691A0E-B805-4D61-B12C-4AFD5BDD668DQ51553189-A99EF653-843B-4FB2-A916-2A05C475E4D0Q51562983-A1C29E21-351F-4BD7-9F54-7573DF9436B3Q51575789-A0ABAD5F-5F22-40A6-9A3E-A31A38F81B8C
P2860
Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Insulin-like growth factor-I i ...... m in type 2 diabetes mellitus.
@ast
Insulin-like growth factor-I i ...... m in type 2 diabetes mellitus.
@en
type
label
Insulin-like growth factor-I i ...... m in type 2 diabetes mellitus.
@ast
Insulin-like growth factor-I i ...... m in type 2 diabetes mellitus.
@en
prefLabel
Insulin-like growth factor-I i ...... m in type 2 diabetes mellitus.
@ast
Insulin-like growth factor-I i ...... m in type 2 diabetes mellitus.
@en
P2093
P2860
P356
P1476
Insulin-like growth factor-I i ...... m in type 2 diabetes mellitus.
@en
P2093
Froesch ER
Jaeggi-Groisman SE
P2860
P304
P356
10.1172/JCI116109
P407
P577
1992-12-01T00:00:00Z